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Objectives. Our objective is to compare maternal plasma procalcitonin concentrations in preterm premature rupture of mem-
branes (pPROM) and premature rupture of membranes (PROM) at term with their levels in uncomplicated pregnancy, and to
determine whether these concentrations are useful in the diagnosis of pPROM cases suspected of infection and in the prediction
of pPROM-to-delivery interval. Study design. Forty eight patients with pPROM, 30 with PROM at term, 31 healthy women at
preterm gestation, and 33 healthy women at term were included. In pPROM group, analysis of procalcitonin concentrations with
reference to leucocytosis, serum C-reactive protein, vaginal ﬂuid culture, neonatal infection, histological chorioamnionitis and
pPROM-to-delivery interval was carried out. Results. Procalcitonin concentrations in pPROM and PROM at term cases were com-
parable.However,inbothgroupsprocalcitoninvaluesweresigniﬁcantlyhigherthaninhealthycontrolsinapproximategestational
age. In pPROM group, procalcitonin concentrations between the patients with and without laboratory indices of infection were
comparable, as well as between patients who gave birth to newborns with and without congenital infection, and between patients
with and without histological chorioamnionitis. The predictive values of procalcitonin determinations were poor. Conclusion.T h e
value of maternal plasma procalcitonin determinations in the diagnostics of pPROM cases suspected of intraamniotic infection,
as well as for the prediction of pPROM-to-delivery interval, newborn’s infection or histological chorioamnionitis is unsatisfactory.
However, procalcitonin concentrations are elevated, both in patients with preterm and term PROMs in comparison to healthy
pregnants, and therefore further evaluations are necessary to establish the role of procalcitonin in the pathophysiology of preg-
nancy.
Copyright © 2007 Andrzej Torb´ e. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
The management of a patient who presents with preterm
premature rupture of membranes (pPROM) is controversial
andremainsachallengingtaskinperinatalmedicine.Interm
patients, labor may be induced immediately after PROM or
they may be observed for up to 24–72 hours for the onset of
spontaneous labor [1, 2]. Clinical management of pPROM
before 34 weeks of gestation is generally expectant, with con-
troversies sorrounding the use of amniocentesis, corticos-
teroids, and tocolytics. In women without signs of infection,
the current standard of care is hospitalization and bed rest
until there is evidence of ascending infection or documenta-
tion of fetal lung maturity [3, 4].
Primary intraamniotic subclinical infection is one of the
main causes of pPROM and the early identiﬁcation of such
cases is necessary for choosing the proper mode of manage-
ment [3, 5]. However, the number of methods of detecting
subclinical infection is modest and limited. Several studies
have demonstrated that fetal compromise can be suspected
by measuring inﬂammatory mediators not only in amniotic
ﬂuid or in cervicovaginal secretion, but also in the maternal
blood.
Recently procalcitonin (PCT) was acknowledged as a
speciﬁc marker of generalized bacterial infections [6, 7].
In serum of healthy individuals, it is present at less than
0.5ng/mL; but in conditions leading to systemic inﬂamma-
tory response syndrome or sepsis, it rapidly increases to high
levels [8–10]. Although PCT continues to be found increas-
ingly useful in modern clinical practice, there are only a
few published data on PCT in pregnancy [11–13]. In our
own recent study, higher plasma PCT concentrations were
found in preterm labor when compared to healthy pregnants
[12].
The purpose of the present study was
(1) to evaluate and compare plasma PCT concentrations
in pregnancies complicated by pPROM and PROM at term
with their levels in uncomplicated pregnancy,2 Mediators of Inﬂammation
Table 1: Clinical characteristics of the groups.
Clinical charecteristics Group 1 Group 2 Group 3 Group 4
(N = 48) (N = 30) (N = 31) (N = 33)
Maternal age (years) (mean ± SD) 27.5 ± 6.82 7 .8 ±5.32 6 .7 ±4.92 8 .2 ±5.2
Primiparous (N%) 22 (45.8) 15 (50.0) 16 (51.6) 16 (48.5)
Preterm delivery in prior pregnancy (N%) 11 (22.9) 2 (6.2) 4 (12.9) 1 (3.0)
Gestational age at PROM (weeks) (mean ± SD) 30.8 ± 3.33 8 .6 ±1.3– –
Gestational age at delivery (weeks) (mean ± SD) 31.4 ± 3.03 8 .6 ±1.33 8 .9 ±1.44 0 .4 ±1.0
pPROM-to-delivery interval (days) (mean ± SD) 5.5 ±8.10 – –
Cervical dilatation (cm) (mean ± SD) 1.9 ±1.00 .87 ±0.80 .4 ±0.61 .8 ±0.8
Cervical length (cm) (mean ± SD) 1.4 ±0.72 .5 ±1.11 .8 ±0.31 .4 ±0.5
Caesarean section delivery (N%) 26 (54.2) 5 (16.7) 7 (22.6) 10 (30.3)
Birth weight (g) (mean ± SD) 1828 ± 657 3412 ±398 3515 ±467 3650 ±603
Five-minute Apgar score (points) (mean ± SD) 8.5 ±1.49 .7 ±0.69 .7 ±0.69 .5 ±0.8
(2) to determine whether maternal plasma PCT concen-
trations are of value in the diagnosis of pPROM cases sus-
pected of subclinical intraamniotic infection (IAI) and in the
prediction of the length of the pPROM-to-delivery interval.
2. MATERIAL AND METHODS
A total of 142 women with singleton pregnancies was en-
rolled in this study after providing written informed con-
sent. The study was approved by the University Human Sub-
ject Review Committee. Gestational age was based on the
last menstrual period and was conﬁrmed by early second-
trimester ultrasonographic examination. The study popula-
tionwasdividedintofourgroupsandthedemographicchar-
acteristics of them are shown in Table 1.
Women with pPROM between 24 and 34 weeks of preg-
nancy without uterine contractions made up the ﬁrst group.
None of them showed clinical signs of infection or any other
maternal or fetal complications at admission. All patients re-
ceived antibiotics, steroids, and were restricted to bed rest
with fetal heart monitoring and uterine activity assessment
performed twice daily. The second group consisted of 30
women with PROM > 36 weeks without uterine contrac-
tions, and none of them had other diseases or obstetric com-
plications. The induction of labor with intravenous oxy-
tocin was initiated if spontaneous contractions did not ensue
w i t h i n6 – 1 2h o u r s( n = 18; 60%). For PCT evaluations, in
all patients with PROM, venous blood was collected within
4 hours, before administration of any drugs. In both groups,
white blood cell count (WBC) and C-reactive protein (CRP)
wereanalyzed,alsowithin4hoursofPROM.Thethirdgroup
consited of 31 healthy women at preterm gestation, and the
fourth group consisted of 33 healthy women at term not
in labor, with intact membranes. In these patients, venous
blood was collected during routine ambulatory visits.
In all instances, maternal venous blood collected to the
tubes containing EDTA was immediately centrifuged and
then plasma was stored at −35◦C until analysis. For the
measurement of PCT, an immunoluminometric assay was
performed using the LUMItest PCT kit (Brahms Diagnos-
tica, Berlin, Germany) and the luminometer LIA-MAT Sys-
tem300(BYK-SangtecDiagnostica,Dietzenbach,Germany).
The lowest detection limit of PCT with this method was
0.1ng/mL.
In the pPROM group, a detailed analysis of PCT con-
centrations was carried out and the results were compared
to laboratory indices of subclinical IAI, the presence/absence
of neonatal congenital infection, or the presence/absence of
histological chorioamnionitis. The studied patients were also
categorized into those who delivered within and after 24 and
72 hours after pPROM.
WBC was determinated with Celldyn 1700 and 3500
Abbott instruments (Abbott Laboratories, Ill, USA) with a
critical value for analysis over 15.0G/L. CRP was measured
by immunoturbidometry with the Olympus AU 560 system
(Olympus Diagnostica, Hamburg, Germany) with a critical
value for analysis over 10mg/L. In the pPROM group, vagi-
nal ﬂuid was cultured for aerobic and anaerobic bacteria. Fe-
tal outcome was evaluated by a neonatologist according to
clinical signs and laboratory tests of the neonate. Neonatal
infectionwasassumedtobeperinatallyacquiredifitoccured
within 48 hours after delivery. For the diagnosis of histologic
chorioamnionitis, microscopic analysis of the placenta was
performed.
Statistical analysis was performed with Statistica 5.5 and
MedCalc 7.2 software. The Shapiro-Wilk test was used to
check the distribution of analyzed parameters. Diﬀerences
between the groups were analyzed by Mann-Whitney U.t e s t
and Chi2 test. Possible correlation between plasma PCT at
the onset of pPROM and WBC count, CRP level, gestational
age, and the length of pPROM-to-delivery interval were as-
sessed by Spearman’s test. Receiver operator characteristic
curveanalysiswasusedtoestablishthecutoﬀvalueofplasma
PCT that optimized the prediction of pPROM-to-delivery
interval, neonatal infection, and histological chorioamnioni-
tis. Sensitivity, speciﬁcity, positive and negative predictive
values were then calculated. Additionally, the predictive val-
ues of WBC count ≥15.0G/L and plasma CRP ≥10mg/L
were evaluated.Andrzej Torb´ e 3
Table 2:Comparisonofmaternalplasmaprocalcitonin(PCT)con-
centrations between the groups.
Groups n PCT (ng/mL): median
Group 1: pPROM 48 1.97∗†
Group 2: PROM 30 1.60∗‡
Group 3: healthy-preterm gestation 31 1.06†Δ
Group 4: healthy at term 33 0.71‡Δ
Comparison between groups:
∗1a n d2 :N S
†1a n d3 :P = .002
‡2a n d4 :P = .045
Δ3a n d4 :N S
3. RESULTS
Plasma PCT concentrations in patients with pPROM and
with PROM at term were comparable (Table 2). Also WBC
count (12.45 versus 11.35G/L; P = .84) and CRP levels (8.0
versus 6.6mg/L; P = .65) were comparable. However, in
both groups, PCT values were signiﬁcantly higher in com-
parison to healthy controls in approximate gestational age
(Table 2).
The pregnancies complicated by pPROM were subjected
to particulary careful analyses. Laboratory indices suggest-
ing the presence of subclinical IAI were searched by evalu-
ating WBC count, CRP concentration, and vaginal ﬂuid cul-
ture,howeverinthesecasesnoclinicalsignsofinfectionwere
found (Table 3). In 9 (18.75%) positive cultures of vaginal
ﬂuid, Candida albicans was found in 7 cases and Streptococ-
cus B was found in 2 cases.
Although in 29 (60.42%) cases of pPROM, at least one
laboratory parameter suggesting the presence of subclinical
IAI was observed, the diﬀerences in PCT concentrations be-
tween the patients with and without laboratory indices of
infection were not signiﬁcant (Table 3). Also, no correlation
was observed between PCT concentration and WBC count
(r = .01; P = .93) or CRP level (r =− .14; P = .36).
Out of 48 patients enrolled in the pPROM group, 17
(35.42%) neonates developed infection, but plasma PCT
concentrationsoftheirmothers(Table 3),andtheirmothers’
WBC counts (13.60 versus 12.10G/L; P = .10) were compa-
rable to those in women whose newborns were healthy. Only
plasma CRP concentrations of mothers who gave birth to
newborns with congenital infection were signiﬁcantly higher
(12.80 versus 7.40mg/L; P = .01).
In 14 (29.17%) placentas, inﬂammatory changes were
found, however in these patients, PCT concentrations
(Table 3), as well as WBC count (14.40 versus 12.10G/L;
P = .47) and CRP levels (8.67 versus 4.91mg/L; P = .41)
were also compatible to those without changes.
The cutoﬀ value for PCT against newborn’s infection or
histological chorioamnionitis showed that the highest sen-
sitivity and speciﬁcity corresponded to a concentration of
1.9ng/mL, but the predictive values were generally poor, as
well as the predictive values of WBC count and CRP levels
(Table 4).
No correlations were observed between PCT concentra-
tions at the moment of pPROM and gestational age at this
time (r = .07; P = .66). In cases in which regular uterine
contractions appeared spontaneously (n = 33), the relation-
ship between maternal PCT concentrations and the length
of pPROM-to-delivery interval was analyzed, but it failed to
reveal signiﬁcant correlation (r = .14; P = .35).
ComparisonofPCTconcentrationsincasesdelivered,af-
ter the spontaneous appearance of contractions, within 24
hours and 3 days of pPROM and after these times also did
not show signiﬁcant diﬀerences (Table 3). The highest values
in the prediction of delivery within 24 and 72 hours corre-
sponded to a PCT concentration of 1.9ng/mL, but they were
unsatisfactory (Table 4).
4. COMMENT
T h ee a r l yi d e n t i ﬁ c a t i o no fI A Ii sad e s i r a b l eg o a li np a t i e n t s
with term, or particularly with preterm amniorrhexis. Clin-
ical signs of infection are subtle and usually not present in
early chorioamnionitis. Currently, there are no reliable clini-
cal markers to adequately indicate IAI in these patients. Nu-
merous studies have demonstrated that it can be suspected
by measuring various mediators in amniotic ﬂuid. Although
these diagnostic methods are highly accurate, they require
the performance of amniocentesis, which regrettably is an
invasive technique, and may be diﬃcult to perform when
the amniotic ﬂuid volume is signiﬁcantly reduced. There-
fore, alternative methods to assess the microbial status of the
intrauterine environment, indirectly but noninvasively, are
proposed. The maternal serum is an easy approach compart-
ment which oﬀers the possibility of obtaining biological ma-
terial in almost noninvasive way. The usefulness of various
markers in the management of pPROM cases, such as proin-
ﬂammatory cytokines, CRP, WBC, neutrophil counts, gran-
ulocyte elastase, ferritin or glycodelin, was previously evalu-
ated [4, 14–20]. Recently, Assi et al. [21] described a signiﬁ-
cantincreaseofmaternalplasmaconcentrationsofpentraxin
3, which is an inﬂammatory molecule belonging to the fam-
ily of CRP, in pregnancies complicated by preterm delivery.
PCT is a new parameter used in the diagnosis of gener-
alized or systemic infectious diseases. In view of the proba-
bly infectious etiology of PROM, one of the purposes of this
study was to determine whether maternal plasma PCT con-
centrations might have any value in the diagnosis and man-
agement of these cases.
The ﬁrst goal of this study was to determine whether
maternal serum PCT concentrations between pPROM and
PROMattermandhealthypregnantsarediﬀerentorcompa-
rable. It was observed that PCT levels in pPROM were com-
parable to those in cases of amniorrhexis at term. However,
in both situations they were signiﬁntly higher than in cases
without complications of the same gestational week, which
may represent additional evidence conﬁrming the hypoth-
esis about the infectious etiology of rupture of the mem-
branes.
The pregnancies complicated by pPROM were subjected
to particulary careful analyses. However, we did not observe
clinical signs of infection in any of the cases, in over 60%
at the onset of pPROM, at least one laboratory parameter4 Mediators of Inﬂammation
Table 3: Plasma procalcitonin (PCT) concentrations of pregnant women with pPROM in relation to the presence of indicators of the
infection, newborn status, histological chorioamnionitis, and pPROM-to-delivery time.
N PCT (ng/mL): median P value
Leucocytosis
≤15.0G/L 35 2.11 .40
>15.0G/L 13 1.51
CRP
≤10mg/L 30 1.61 .50
>10mg/L 18 2.21
Vaginal ﬂuid culture Negative 41 1.71 .19
Positive 7 3.15
Newborn Healthy 31 2.01 .35
Infected 17 1.92
Placenta Lack of changes 34 2.13 .67
Inﬂammatory changes 14 2.83
Delivery Within 24 hours 11 2.14 .84
After 24 hours 22 1.49
Delivery Within 72 hours 21 1.71 .57
After 72 hours 12 2.31
Table 4: The prognostic value of maternal plasma procalcitonin (PCT), white blood cell (WBC) count, and C-reactive protein (CRP)
determinations in the prediction of newborn’s congenital infection, histological chorioamnionitis, and pPROM-to-delivery interval. PPV
denotes positive predictive value; NPV denotes negative predictive value.
Congenital Histological Delivery Delivery
infection chorioamnionitis within 24 hours within 72 hours
PCT ≥1.9ng/mL
Sensitivity (%) 53 75 55 48
Speciﬁcity (%) 45 45 55 50
PPV (%) 35 35 38 63
NPV (%) 64 82 71 35
WBC ≥15.0G/L
Sensitivity (%) 48 33 29 28
Speciﬁcity (%) 85 80 83 88
PPV (%) 63 44 50 80
NPV (%) 76 71 67 42
CRP ≥10mg/L
Sensitivity (%) 52 33 35 34
Speciﬁcity (%) 76 64 79 88
PPV (%) 52 31 50 83
NPV (%) 76 67 68 44
suggesting the presence of subclinical IAI was observed and
over 35% neonates developed congenital infection. Our re-
sults showed that plasma PCT concentrations do not corre-
late signiﬁcantly with laboratory indices suggestive of sublin-
ical infection and that PCT values do not diﬀer between sub-
groups of women with and without laboratory indices of in-
fection at the onset of pPROM. A cutoﬀ value of ≥1.9ng/mL
predicted neonatal infection, histological chorioamnionitis,
or delivery within 24 and 72 hours from pPROM with a sen-
sitivity of 53%, 75%, 55%, 48%, and with a speciﬁcity of
45%, 45%, 55%, 50%, respectively.
In conclusion, our ﬁndings suggest that the value of ma-
ternal plasma procalcitonin determinations in the diagnos-
tics of pPROM cases suspected of subclinical IAI, as well as
for the prediction of pPROM-to-delivery interval, newborns
infection or histological chorioamnionitis is unsatisfactory.
However, PCT concentrations are elevated, both in patients
with preterm and term PROMs in comparison to healthy
pregnants, and therefore further evaluations are necessary
to establish the role of PCT in the pathophysiology of preg-
nancy.
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